Recursion Enters into Agreements to Acquire Cyclica and Valence to Bolster Chemistry and Generative AI Capabilities
SALT LAKE CITY and TORONTO and MONTRรAL, May 08, 2023 (GLOBE NEWSWIRE) โ Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to